Angle Health announces $200M Series C and a $400M shareholder tender
Vitruvian led Angle Health's announced $200M Series C, while a separate $400M tender will provide shareholder liquidity. The transaction is expected to close later in September.
By RuntimeWire Staff · Published
Primary source: Business Wire
Why it matters
Angle has announced $200M in new primary capital, subject to the transaction closing later in September. The separate $400M tender is shareholder liquidity rather than money available to fund the company's expansion.
Ty Wang and Anirban Gangopadhyay's Angle Health announced a $200 million Series C on September 18th, paired with a $400 million tender offer for existing shares at a multibillion-dollar valuation. The transaction, detailed in a Business Wire announcement, is expected to close later in September.…
When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.